Renaissance Capital

Renaissance Capital is a leading provider of institutional IPO research and investment management services, specializing in the analysis of newly public companies. The firm is widely recognized for its IPO Intelligence platform, which provides data and insights on initial public offerings across all sectors, including a significant focus on the biotechnology and healthcare industries. Renaissance Capital also manages a suite of IPO-focused exchange-traded funds (ETFs), such as the Renaissance IPO ETF (NYSE: IPO), which tracks the performance of recent US-listed public offerings. While the firm is a critical resource for biotech analysts tracking sector trends and new market entrants, it does not engage in drug development or clinical research itself. Its primary business revolves around financial data, market research, and investment products.